127 related articles for article (PubMed ID: 10450990)
1. 1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.
Vinh TK; Ahmadi M; Delgado PO; Perez SF; Walters HM; Smith HJ; Nicholls PJ; Simons C
Bioorg Med Chem Lett; 1999 Jul; 9(14):2105-8. PubMed ID: 10450990
[TBL] [Abstract][Full Text] [Related]
2. 1-[(Benzofuran-2-yl)phenylmethyl]triazoles as steroidogenic inhibitors: synthesis and in vitro inhibition of human placental CYP19 aromatase.
Vinh TK; Yee SW; Kirby AJ; Nicholls PJ; Simons C
Anticancer Drug Des; 2001; 16(4-5):217-25. PubMed ID: 12049480
[TBL] [Abstract][Full Text] [Related]
3. Benzofuran- and furan-2-yl-(phenyl)-3-pyridylmethanols: synthesis and inhibition of P450 aromatase.
Saberi MR; Shah K; Simons C
J Enzyme Inhib Med Chem; 2005 Apr; 20(2):135-41. PubMed ID: 15968818
[TBL] [Abstract][Full Text] [Related]
4. Effect of the aromatase inhibitor, MEN 11066, on growth of two different MCF-7 sublines.
Palma C; Criscuoli M; Lippi A; Muratori M; Mauro S; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):93-101. PubMed ID: 11104822
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of 4-(4'-aminobenzyl)-2-oxazolidinones as novel inhibitors of the cytochrome P-450 enzyme aromatase.
Ahmed S; Adat S; Murrells A; Owen CP; Amanuel Y
Bioorg Chem; 2002 Oct; 30(5):315-31. PubMed ID: 12485592
[TBL] [Abstract][Full Text] [Related]
6. Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.
Saberi MR; Vinh TK; Yee SW; Griffiths BJ; Evans PJ; Simons C
J Med Chem; 2006 Feb; 49(3):1016-22. PubMed ID: 16451067
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of aromatase (P450Arom) by some 1-(benzofuran-2-ylmethyl)imidazoles.
Owen CP; Nicholls PJ; Smith HJ; Whomsley R
J Pharm Pharmacol; 1999 Apr; 51(4):427-33. PubMed ID: 10385215
[TBL] [Abstract][Full Text] [Related]
8. Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo.
Whomsley R; Fernandez E; Nicholls PJ; Smith HJ; Lombardi P; Pestellini V
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):675-6. PubMed ID: 8476782
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships and binding model of novel aromatase inhibitors.
Lang M; Batzl C; Furet P; Bowman R; Häusler A; Bhatnagar AS
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):421-8. PubMed ID: 8476755
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.
Abul-Hajj YJ; Liu XP; Hedge M
Steroids; 1995 May; 60(5):423-7. PubMed ID: 7570717
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of estrogen synthetase (aromatase) by 4-cyclohexylaniline.
Kellis JT; Vickery LE
Endocrinology; 1984 Jun; 114(6):2128-37. PubMed ID: 6723577
[TBL] [Abstract][Full Text] [Related]
12. Imidazole derivatives of pyrrolidonic and piperidonic as potential inhibitors of human placental aromatase in vitro.
Baroudi M; Robert J; Luu-Duc C
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):73-7. PubMed ID: 8645619
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a new type of non steroidal human aromatase inhibitors.
Sonnet P; Guillon J; Enguehard C; Dallemagne P; Bureau R; Rault S Auvray P; Moslemi S; Sourdiane P; Galopin S; Séralini GE
Bioorg Med Chem Lett; 1998 May; 8(9):1041-4. PubMed ID: 9871704
[TBL] [Abstract][Full Text] [Related]
14. [The inhibitory effect of miconazole on aromatase activity for androstenedione in human placental and ovarian preparations].
Yamamoto T; Urabe M; Okada H
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1379-85. PubMed ID: 3443212
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor.
Muratori M; Lippi A; Mancina R; Iafrate EM; Cirillo R; Lopez G; Bigioni M; Maggi M; Criscuoli M; Maggi CA
J Steroid Biochem Mol Biol; 2003 Apr; 84(5):503-12. PubMed ID: 12767275
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture.
Yue W; Brodie AM
J Steroid Biochem Mol Biol; 1997; 63(4-6):317-28. PubMed ID: 9459198
[TBL] [Abstract][Full Text] [Related]
17. Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase.
Santner SJ; Rosen H; Osawa Y; Santen RJ
J Steroid Biochem; 1984 Jun; 20(6A):1239-42. PubMed ID: 6748639
[TBL] [Abstract][Full Text] [Related]
18. Ovine placental aromatase: studies of activity levels, kinetic characteristics and effects of aromatase inhibitors.
France JT; Mason JI; Magness RR; Murry BA; Rosenfeld CR
J Steroid Biochem; 1987 Aug; 28(2):155-60. PubMed ID: 3626552
[TBL] [Abstract][Full Text] [Related]
19. Inhibition study of human placental aromatase with 3-deoxy- and 6-oxo-steroids using [1 beta-3H]16 alpha-hydroxyandrostenedione as a substrate: a comparison to that using [1 beta-3H]androstenedione.
Numazawa M; Mutsumi A
J Steroid Biochem Mol Biol; 1993 Feb; 44(2):199-201. PubMed ID: 8439524
[TBL] [Abstract][Full Text] [Related]
20. [Aromatase inhibitors: pharmacological aspects].
de Crémoux P
Bull Cancer; 2000 Dec; 87 Spec No():23-29. PubMed ID: 11250605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
